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Abstract Migraine causes major health impairment and
disability. Psychological interventions offer an addition to
pharmacotherapy but they are not currently recommended
by the National Institute of Clinical Excellence (NICE) or
available in the National Health Service. We aimed to
systematically review evidence on the efficacy of psycho-
logical interventions for migraine in adults. A search was
done of MEDLINE, psychINFO, http://www.opengrey.eu,
the meta-register of controlled trials and bibliographies.
Twenty-four papers were included and rated independently
by two people using the Yates scale, which has 35 points.
Cochrane recommendations are that high quality reports
score above the mid-point (18 points). Methods used in
17/24 papers were rated ‘high quality’. However, fre-
quently descriptions of key areas such as randomisation
methods were omitted. Eighteen studies measured effects
of psychological interventions on headache-related out-
comes, fifteen reporting significant improvements, ranging
20–67 %. Interventions also produced improvements in
psychological outcomes. Few trials measured or reported
improvement in disability or quality of life. We conclude
that evidence supports the efficacy of psychological inter-
ventions in migraine. Over half of the studies were from
the USA, which did not provide universal health care at the
time of the study, so it is difficult to generalise results to
typical populations in receipt of publically funded health
services. We agree with the NICE recommendation that
high quality pragmatic randomised controlled trials are
needed in the UK.
Keywords Migraine  Headache  Systematic review 
Relaxation  Cognitive behavioural therapy  Biofeedback
Introduction
Migraine is a profoundly debilitating condition ranked by the
World Health Organisation (WHO) as one of the top 20
causes of disability worldwide [1]. It results in loss of quality
of life (QoL) aswell as having a significant impact on society
as a whole. In the United Kingdom (UK), approximately 25
million work days are lost to migraine each year, with
headache disorders estimated to cost the economy in excess
of £5 billion per year [2, 3]. Current treatment for migraine is
primarily focussed on pharmacological interventions, how-
ever, these treatments only show moderate efficacy. With
headache disorders now considered a bio-psychosocial
phenomenon, pharmacotherapy fails to address underlying
psychological and social factors influencing headache [4].
Evidence also shows that migraine may be comorbid with
psychiatric conditions, notably anxiety and depression [5].
As such, psychological interventions are considered as a
possible alternative or adjunct to pharmacotherapy.
The main psychological interventions employed as
treatment for migraine include relaxation training (RT),
cognitive behavioural therapy (CBT) and biofeedback (BF).
Despite over 40 years of research into these treatments and
endorsement by organisations worldwide including the US
Headache Consortium and WHO, they are not currently
recommended for use in migraine patients in the UK [6, 7].
However, in 2012, the National Institute of Clinical Excel-
lence (NICE) issued a research recommendation for a
& Leone Ridsdale
leone.ridsdale@kcl.ac.uk
1 King’s College London, Denmark Hill Campus,
PO57, London SE5 8AF, UK
123
J Neurol (2016) 263:2369–2377
DOI 10.1007/s00415-016-8126-z
pragmatic randomised controlled trial (RCT) to be con-
ducted to determine the efficacy of psychological interven-
tions for treatment of chronic headache, perhaps paving the
way for future provision of these interventions inUK clinical
practice [8]. To this end, a pilot trial was undertaken at
King’s College London to assess the feasibility of trialling
CBT combinedwith RT for chronicmigraine in adults [9]. In
this context, we reviewed the literature on psychological
interventions for migraine at this time.
Goslin et al. [10] previously systematically reviewed
psychological interventions for migraine in 1999 concluding
that BF, RT and CBT have modest efficacy. Subsequent
systematic reviews have since focussed on BF and paediatric
populations [11–13]. Therefore, an up-to-date overview of
the psychological interventions for adult migraineurs is
currently needed. In light of this, we aimed to systematically
review the evidence regarding the efficacy of psychological
interventions for treatment of adult migraine since 1999.
Methods
Selection criteria
Trials were included if they (1) included participants with a
diagnosis of migraine; (2) employed BF, RT and/or CBT as
an intervention; (3) were published from 1999 to 2014; (4)
were a RCT; (5) were in English.
Studies were excluded if (1) they did not report a
specific headache diagnosis; (2) they included populations
of other headache disorders such as cluster headache; (3)
they employed non-psychological interventions such as
physical therapy; (4) there were no results published; (5)
only physiological outcomes were reported.
Studies with mixed populations of migraine and tension
type headache (TTH) were included because, these disor-
ders represent a heterogeneous group and to exclude such
studies would exclude a significant part of the migraine
literature. Goslin et al. [10] also included such studies in
their review.
Search strategy
An electronic search was carried out, for published and
unpublished trials, of the databases (1) MEDLINE; (2)
psychINFO; (3) opengrey.eu; and (4) the meta-register of
controlled trials. This was carried out using the key words
‘‘migraine disorder’’, ‘‘migraine with aura’’, ‘‘migraine
without aura’’, ‘‘migraine’’ and ‘‘migraine headache’’
combined with ‘‘cognitive therapy’’, ‘‘behaviour therapy’’,
‘‘cognitive behavioural therapy’’, ‘‘relaxation therapy’’,
‘‘relaxation training’’ and ‘‘biofeedback’’. A manual search
of relevant bibliographies was also performed.
Quality assessment
Texts included were quality assessed by two independent
people using the Yates scale [14]. After one round of rat-
ings, they were compared, and if there were disagreements,
raters reassessed in a second round of ratings. Subse-
quently, further disagreements were taken to the principal
investigator (Leone Ridsdale) for resolution. The Yates
scale is scored out of 35 points with 26 items assessed,
including some specific to psychological interventions such
as assessment of therapist training and treatment expecta-
tions. This scale has been deemed to have good construct
validity and reliability [15]. Furthermore, it has had a rig-
orous development through a standardised procedure [14,
15]. The ‘therapist training’ criterion of the scale was
excluded when a therapist was irrelevant to the intervention
such as in ‘self-help’ treatments. In this case, trials were
scored out of 33 instead of 35. A percentage was calculated
from the final score so that trials could be compared
regardless of whether they were scored out of 33 or 35.
A Cochrane review used the mid-point (score of 18) as the
divider between a ‘high quality’ and ‘low quality’ study
[16]. So with ratings converted to percentages in this
review, a score C50 % was deemed high quality and a
score B49 % was deemed low quality.
Results
The initial database search returned 1123 hits with a further
two records identified through bibliographic searching.
Following screening and full text assessment, 24 publica-
tions were included in the review. Figure 1 shows the
PRISMA flow diagram of the review process.
Table 1 shows a summary of publications included in
the review. Taking account of secondary analyses (see
Table 1: 3b, 12b, 17b and 17c) and follow up studies (see
Table 1: 10b), there were 19 separate studies.
Twelve studies included a population with a diagnosis of
migraine only, and seven included populations with a
diagnosis of migraine and/or TTH. Ten studies were based
on North American populations; the remainder were
European (n = 6), Asian (n = 2) and Australian (n = 1),
with none from the UK.
Trialists tended to opt for interventions consisting of a
combination of psychological treatments, with CBT ? RT,
the most commonly adopted approach (n = 6). Other
treatment combinations included BF ? RT (n = 2) and
combinations of all three modalities (n = 2). One study
employed CBT on its own, four RT on its own and two BF
on its own. Two studies used interventions that did not
strictly fall into the CBT, RT or BF category. These
employed meditation and behavioural sleep management
2370 J Neurol (2016) 263:2369–2377
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as interventions, which were deemed directly related and so
were included in the review.
Comparison groups used in the studies were variable
(see Table 1 for details). Most commonly, a wait-list
control group was used (n = 5). Other control groups used
included pharmacological interventions, self-help and self-
relaxation.
The outcome measures used fell into four categories:
headache, psychological, disability and QoL. Eighteen
studies directly measured the effect of the intervention on
headache outcome measures. Fifteen of these reported that
psychological interventions significantly improved head-
ache outcome measures ranging from 20 to 67 %. Eleven
studies reported headache frequency/days as measured by
daily self-reporting, the recommended outcome measure
for headache trials [41, 42]. Studies showed a 21–67 %
improvement in this measure, after intervention (see
Table 1). The largest improvement was seen when a
combination of CBT, RT and BF were provided in con-
junction with pharmacotherapy [36]. Fifteen studies
assessed psychological outcomes with four out of eight
studies reporting significant improvements in anxiety and
six out of ten reporting improvements in depression,
ranging 14–32 % and 18–62 %, respectively. Eight studies
assessed disability with psychological interventions yield-
ing improvements of 28–44 % in four of the studies. Seven
assessed impact on QoL, with three reporting improved
QoL following intervention, ranging from 5 to 39 %.
Seventeen out of the 24 publications were graded as
high quality. Nevertheless, descriptions of key areas of
methodology were omitted. For example, despite all pub-
lications reporting that participants were randomised, only
nine provided an adequate description of randomisation.
Similarly, publications often failed to report how they
minimised allocation bias and measurement bias. Only four
publications were deemed to have adequate control groups
that were well matched to the intervention group and only
three used outcome measures that were validated. Only one
study was blinded to study participants, but this is difficult
in complex-intervention trials, and only one study assessed
the treatment expectations of study participants.
Discussion
The range of efficacy of psychological interventions was
broad, from 20 to 67 %. There was no evidence to indicate
that one approach of CBT, RT or BF was superior to
Records identified through 
database searching 
(n = 1123) 
Additional records identified 
through other sources 
(n = 2) 
Records after duplicates removed 
(n = 929) 
Records screened 
(n = 929) 
Records excluded 
(n = 898) 
Full-text articles 
assessed for eligibility 
(n = 31) 
Full-text articles 
excluded, with reasons 
(n = 7) 
Inappropriate design 
(not RCT) (n=5) 
Inappropriate population 
(n=1) 
Outcome not relevant to 
research question (n=1) 
Studies included in 
qualitative synthesis 
(n = 24) 
Fig. 1 PRISMA flow diagram
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another. Since Goslin et al. [8] last reviewed the literature
in 1999, the most favoured behavioural approach to
migraine has been CBT ? RT, in particular, minimal-
contact interventions. These low intensity interventions
demonstrated a modest efficacy in migraine reduction,
which is of particular relevance because, such approaches
are likely to be less costly, hence, potentially more cost-
effective [43]. A recent paper provides some understanding
of patients’ views using qualitative methods, with inter-
views [9, 44]. Combining trial methodology with qualita-
tive methods is recommended by the Medical Research
Council, but so far not used in trials of psychological
interventions for migraine [45]. The study of minimal-
contact CBT ? RT reported that participants found the
relaxation aspects of therapy easier to implement. CBT
components of therapy were more challenging to learn and
apply in the context of a minimal-contact intervention [44].
Improvements in headache seen in this review in studies
using CBT related interventions are less than those repor-
ted by Goslin et al. [10]. This is in part due to more
intensive approaches used by earlier studies. Higher con-
tact therapy, unsurprisingly, has had a larger effect than
minimal contact, so a balance must be struck to maximise
efficacy and minimise cost [46].
In our review, we note a large range in the efficacy of
psychological interventions for migraine. Differences in
the intensity of therapeutic contact may in part explain this.
However, it may also be attributed to diversity in thera-
peutic interventions that make up CBT, RT and BF. For
example, of the studies that employed RT as part of their
intervention, both autogenic training and progressive
muscle relaxation were employed in different studies as
well as combinations of the two. CBT interventions were
particularly diverse, combining various aspects of educa-
tion and management strategies for triggers, stress and fear
among others. This significant heterogeneity within inter-
vention types makes it difficult to compare results and
ascertain if there is an optimum therapy design. Few
studies compare the effect of behavioural interventions
with pharmacological interventions; however, of the two
that did, no significant differences in efficacy were noted
[22, 33]. Pharmacotherapy and behavioural therapy may be
complementary in nature with the greatest magnitude of
reduction (67 %) in headache frequency achieved by
implementing a combination of the two [36].
Studies in our sample were often lacking in quality in
key areas. Problems in methodology were similarly
reported in the review by Rains et al. [47]. In our sample,
poor reporting of randomisation methods was common.
Blinding was also a challenge, with only 1 study blinding
subjects. However, considering that blinding in psycho-
logical interventions is often not possible, one could assess
the expectations of patient to treatment as an alternative.
Still, only 1 reported such an assessment, making exclud-
ing ‘placebo’ effects difficult. Few studies used outcome
measures that were all considered valid. This is in part
because, the recommended outcome measure for headache
trials is daily self-report headache frequency/days, which
strictly speaking is not a validated measure, therefore, the
Yates scale may have shown unnecessary bias against these
studies [41, 42].
There were several limitations to our review. Firstly,
studies included populations of not only migraine but also
TTH. This was done to ensure that we included as much of
the migraine trial evidence as possible. However, we can-
not be sure with these studies whether treatment effects
were due to effects on migraine or TTH or both; this may
also be a reason behind the wide range in efficacy that
interventions appeared to have. Secondly, the outcome
measures of the studies in our sample were heterogeneous.
This makes it difficult for us to make a comparison
between all of the studies and draw solid conclusions
regarding efficacy. We have illustrated percentage reduc-
tion of headache frequency as measured by prospectively
recorded self-report measures in Table 1. This is a rec-
ommended outcome measure, however, the number of
studies using this was limited. We did not include other
headache outcome measures such as headache index
because, these are not favoured by guidelines [41]. Fur-
thermore, headache frequency reported retrospectively was
not included because, they are less reliable than prospec-
tive studies of headache frequency [41, 48]. In future, the
use of a core outcome set would reduce heterogeneity and
strengthen the evidence-base for psychological interven-
tions for migraine.
The evidence included suggests that psychological
interventions can be effective for migraine; a significant
portion of this evidence favoured a CBT ? RT approach.
The evidence-base is still lacking in quality, and partici-
pants were not generally representative of those receiving
publicly universal care, as provided in the National Health
Service. The NICE guidelines call for pragmatic RCT’s of
psychological interventions for headache [8]. Our pilot trial
begins to address this issue and may provide foundations
for further testing of psychological interventions for
migraine in the UK [9].
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